FrancophonIA/ELRC3.0 huggingface dataset:
English: As examples: - In a comatose child, start with a dose of 100 to 250 mg/kg/day and measure ammonia plasma concentration at least before each administration; it should normalise within a few hours after starting Ucedane.
Danish: Som for eksempel: - Hos et komatøst barn startes med en dosis på 100 til 250 mg/kg/dag og ammoniak plasmakoncentration måles i det mindste før hver indgivelse; den skulle normaliseres indenfor et par timer efter start med Ucedane.
English: This medicine is for oral use ONLY (ingestion or via nasogastric tube using a syringe, if necessary).
Danish: Dette lægemiddel er KUN til oral anvendelse (indtagelse eller via nasogastrisk sonde vha. en sprøjte, hvis det er nødvendigt).
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Danish: Yderligere information om dette lægemiddel er tilgængelig på Det Europæiske Lægemiddelagenturs (EMAs) hjemmeside http://www.ema.europa.eu/.
English: At that dose-level, in 12 volunteers given carglumic acid tablets, plasma concentration peaked at 2.6 μg/mL (median; range 1.8-4.8) after 3 hours (median; range 2-4).
Danish: Ved dette dosisniveau, givet som cargluminsyretabletter til 12 frivillige, blev der opnået maksimale plasmakoncentrationer på 2,6 µg/ml (median; værdier mellem 1,8 og 4,8) efter 3 timer (median; værdier mellem 2 og 4).
English: The tablets are rod-shaped, white and biconvex with three score lines on both sides and engraving “L/L/L/L” on one side.
Danish: Tabletterne er aflange, hvide og bikonvekse med tre delekærve på begge sider og præget med “L/L/L/L” på den ene side.
English: Carglumic acid responsiveness test It is recommended to test individual responsiveness to carglumic acid before initiating any long term treatment.
Danish: Cargluminsyre-responstest Det anbefales at teste individuelt respons på cargluminsyre, inden der indledes længevarende behandling.
English: Ucedane can help eliminating excessive ammonia plasma levels (elevated ammonia level in the blood).
Danish: Ucedane kan medvirke til eliminere usædvanligt høje niveauer af ammoniak i blodet (hyperammonæmi).
English: Ucedane dispersible tablets are rod-shaped, white, and biconvex with three score lines on both sides and engraving “L/L/L/L” on one side.
Danish: Ucedane brusetabletter er aflange, hvide og bikonvekse med tre delekærve på begge sider og præget med “L/L/L/L” på den ene side.
English: Hyperammonaemia may be due to the lack of a specific liver enzyme N- acetylglutamate synthase.
Danish: Hyperammonæmi kan skyldes mangel på et specifikt leverenzym, N-acetylglutamatsyntase.
English: Effects on the ability to drive and use machines are not known.
Danish: Virkninger på evnen til at køre bil og betjene maskiner er ukendt.
English: Despite a lower affinity of carbamoyl phosphate synthetase for carglumic acid than for Nacetylglutamate, carglumic acid has been shown in vivo to stimulate carbamoyl phosphate synthetase and to be much more effective than N-acetylglutamate in protecting against ammonia intoxication in rats.
Danish: På trods af en lavere affinitet for carbamoylfosfatasesyntetase overfor cargluminsyre end overfor N-acetylglutamat, har cargluminsyre in vivo vist sig at stimulere carbamoylfosfatasesyntetase og at være langt mere effektiv end N-acetylglutamat til at beskytte mod ammoniakforgiftning hos rotter.
English: When the patient is in hyperammonaemic coma, Ucedane is administered by fast push through a syringe via the tube set up and used to feed you.
Danish: Når patienten er i hyperammonæmisk coma, gives Ucedane ved et hurtigt tryk gennem en sprøjte via den sonde, der er lagt for at ernære Dem.
English: - The other ingredients are microcrystalline cellulose, colloidal anhydrous silica,
Danish: - Øvrige indholdsstoffer: mikrokrystallinsk cellulose, kolloid vandfri silica,
English: Other medicines and Ucedane
Danish: Brug af anden medicin sammen med Ucedane
English: Uncommon bradycardia
Danish: Ikke almindelig bradykardi
English: Uncommon pyrexia
Danish: Ikke almindelig pyreksi
English: If you get any side effects, talk to your doctor or, pharmacist.
Danish: Hvis du oplever bivirkninger, bør du tale med din læge, sygeplejerske eller apoteket.
English: Carglumic acid is secreted in the milk of lactating rats and although developmental parameters were unaffected, there were some effects on body weight / body weight gain of pups breast-fed by dams treated with 500 mg/kg/day and a higher mortality of pups from dams treated with
Danish: Cargluminsyre udskilles i mælken hos ammende rotter, og selvom udviklingsparametre var upåvirkede, var der somme tider en effekt på kropsvægt/forøgelse af kropsvægt hos unger, der diede ved mødre behandlet med 500 mg/kg/dag og en højere mortalitet hos unger af mødre behandlet med 2000 mg/kg/dag, en modertoksisk dosis.
English: - if you are allergic to carglumic acid or any of the other ingredients of this medicine (listed in section 6); - during breast-feeding.
Danish: - hvis De er allergisk over for cargluminsyre eller et af de øvrige indholdsstoffer i Ucedane (angivet i pkt.
English: In the long term, the daily dose usually ranges from 10 mg to 100 mg per kilogram of body weight.
Danish: Den daglige dosis ved langvarig behandling ligger sædvanligvis i intervallet fra 10 mg til 100 mg pr. kilo legemsvægt.
English: • increased sweating
Danish: - øget svedtendens
English: Uncommon diarrhea, vomiting
Danish: Ikke almindelig diarré, opkastning
English: 12 dispersible tablets
Danish: 12 dispergible tabletter
English: Breast-feeding Although it is not known whether carglumic acid is secreted into human milk, it has been shown to be present in the milk of lactating rats (see section 5.3).
Danish: Selvom det ikke vides, om cargluminsyre udskilles i human brystmælk, er stoffet blevet påvist i mælken fra ammende rotter (se pkt.
English: Pack size of 12 or 60 dispersible tablets.
Danish: Pakningstørrelse på 12 eller 60 dispergible tabletter.
English: 60 dispersible tablets
Danish: 60 dispergible tabletter
English: - The active substance is carglumic acid.
Danish: - Aktivt stof: cargluminsyre.
English: This leaflet was last revised in {MM/YYYY} Other sources of information
Danish: Denne indlægsseddel blev senest ændret {MM/ÅÅÅÅ}.
English: For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Danish: Hvis De vil have yderligere oplysninger om dette lægemiddel, skal De henvende Dem til den lokale repræsentant:
English: - This medicine has been prescribed for you only.
Danish: - Lægen har ordineret Ucedane til Dem personligt.
English: Ucedane 200 mg dispersible tablets carglumic acid
Danish: Ucedane 200 mg dispergible tabletter cargluminsyre
English: Ucedane 200 mg dispersible tablets
Danish: Ucedane 200 mg dispergible tabletter
English: The excretion of carglumic acid into breast milk has not been studied in women.
Danish: Det er ikke undersøgt, om cargluminsyre udskilles i brystmælk hos kvinder.
English: Contents of the pack and other information What Ucedane contains
Danish: Pakningsstørrelser og yderligere oplysninger Ucedane indeholder:
English: Common increased sweating
Danish: Almindelig øget svedtendens
English: Ucedane is indicated in treatment of hyperammonaemia due to N-acetylglutamate synthase primary deficiency.
Danish: Ucedane er indiceret til behandling af hyperammonæmi på grund af primær Nacetylglutamatsyntasemangel.
English: PHARMACEUTICAL PARTICULARS 6.1 List of excipients microcrystalline cellulose, mannitol, colloidal anhydrous silica, sodium stearyl fumarate, crospovidone type B, copovidone K 28.
Danish: Mikrokrystallinsk cellulose mannitol kolloid vandfri silica natriumstearylfumarat crospovidon type B copovidon K 28.
English: How to take Ucedane
Danish: Sådan skal De tage Ucedane
English: - If you have any further questions, ask your doctor, or pharmacist.
Danish: Er De i tvivl, så spørg lægen eller apotekspersonalet.
English: Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Danish: Indlægsseddel: Information til brugeren Ucedane 200 mg dispergible tabletter Cargluminsyre Læs hele denne indlægsseddel grundigt, inden De begynder at tage dette lægemiddel, da den indeholder vigtige oplysninger.
English: What you need to know before you take Ucedane 3.
Danish: Det skal De vide, før De begynder at tage Ucedane Sådan skal De tage Ucedane Bivirkninger
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON X 60 TABLETS
Danish: YDRE ÆSKE X 60 TABLETTER
English: Nevertheless, as carglumic acid has been shown to be present in the milk of lactating rats with potential toxic effects for their fed pups, you must not breast-feed your baby if you are taking Ucedane.
Danish: Ikke desto mindre må De ikke amme Deres barn, hvis De tager Ucedane, da tilstedeværelse af cargluminsyre er blevet påvist i mælken hos ammende rotter med potentielt toksiske virkninger for ungerne.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON X 12 TABLETS
Danish: YDRE ÆSKE X 12 TABLETTER
English: If you take more Ucedane than you should
Danish: Hvis De har taget for meget Ucedane
English: What Ucedane looks like and contents of the pack
Danish: Udseende og pakningsstørrelser
English: Nutritional management
Danish: LISTE OVER HJÆLPESTOFFER
English: March 2015 CMDh
Danish: Marts 2015 CMDh
English: 19 June 2015
Danish: 19. juni 2015
English: Implementation of the agreement by the Member States (submission of the Type IB variation by the Marketing Authorisation Holder):
Danish: Aftalen gennemføres i medlemsstaterne (type IB-ændringsansøgning indsendes af indehaveren af markedsføringstilladelsen):
English: Annex IV
Danish: Bilag IV Tidsplan for gennemførelse af aftalen
English: This summary was last updated in May 2013.
Danish: Dette sammendrag blev sidst ajourført i maj 2013.
English: The vaccine was generally well tolerated as demonstrated by the absence of major systemic reactions.
Danish: Vaccinen tåltes generelt godt, som synliggjort ved fraværet af større systemiske reaktioner.
English: Protection starts three weeks after the last injection and lasts for one year.
Danish: Beskyttelsen virker tre uger efter den sidste injektion og holder ét år.
English: The first injection is given from one and a half months age and the second injection is given three weeks later.
Danish: Den første injektion gives, fra de er halvanden måned gamle, og den anden injektion gives tre uger senere.
English: There may be a local reaction at the injection site, such as swelling (lasting no more than one week) or ‘nodules' (hardening under the skin) possibly lasting more than six or seven weeks.
Danish: Der kan forekomme lokale reaktioner på injektionsstedet som f.eks. hævelser (i højst én uge) eller "knuder" (hårdhed under huden), som kan vare i mere end seks eller syv uger.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for ZULVAC 1+8 Ovis on 14 March 2011.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for ZULVAC 1+8 Ovis den 14. marts 2011.
English: Sheep may show a temporary increase in rectal temperature, not more than 1.2 °C in the 24 hours following vaccination.
Danish: Der kan forekomme en forbigående stigning i fårenes rektale temperatur på højst 1,2 °C inden for 24 timer efter vaccinationen.
English: The safety of the vaccine was studied in two main laboratory safety studies carried out in sheep (overdose and single and repeated administration) and two studies carried out in pregnant ewes.
Danish: Vaccinens sikkerhed blev undersøgt i to primære laboratoriesikkerhedsundersøgelser hos får (overdosis samt enkelt og gentagen indgivelse) og to undersøgelser hos drægtige moderfår.
English: ZULVAC 1+8 Ovis was initially authorised under ‘exceptional circumstances'.
Danish: ZULVAC 1+8 Ovis blev oprindeligt godkendt under "særlige omstændigheder".
English: The virus exists in several forms (serotypes) throughout the world; the types used in ZULVAC 1+8 Ovis are serotypes 1 and 8.
Danish: Virusset findes i forskellige former (serotyper) rundt omkring i verden, og de typer, der anvendes i ZULVAC 1+8 Ovis, er serotype 1 og 8.
English: The withdrawal period for ZULVAC 1+8 Ovis for meat and milk is zero days.
Danish: Tilbageholdelsestiden for ZULVAC 1+8 Ovis for kød og mælk er nul dage.
English: The benefitrisk balance may be found in the scientific discussion module of this EPAR.
Danish: Benefit/risk-forholdet fremgår af afsnittet om den videnskabelige drøftelse i denne EPAR.
English: The efficacy of the vaccine was studied in four main laboratory trials in sheep of young age where animals were challenged with both BTV-1 and BTV-8 serotypes using ZULVAC 1-8 Ovis vaccines containing low antigen quantities.
Danish: Vaccinens virkning blev undersøgt i forbindelse med fire primære laboratorieundersøgelser hos unge får, hvor dyrene fik både BTV-1- og BTV-8-serotyper under anvendelse af ZULVAC 1-8 Ovis-vacciner indeholdende lave antigenmængder.
English: Inactivated adjuvanted vaccine against bluetongue disease virus, serotypes 1 and 8
Danish: Inaktiveret, adjuveret vaccine mod bluetongue-virus, serotype 1 og 8
English: In 2013 the CVMP considered that the submitted data were adequate for the authorisation of ZULVAC 1+8 Ovis to convert to a normal status.
Danish: I 2013 konkluderede CVMP, at de forelagte oplysninger var tilstrækkelige for at kunne ændre godkendelsen af ZULVAC 1+8 Ovis til en normal godkendelse.
English: The studies showed that the vaccine is safe for sheep and it prevents viraemia caused by bluetongue Virus, serotypes 1 and 8 in animals from one and a half months of age.
Danish: Undersøgelserne viste, at vaccinen er sikker for får, og at den forebygger viræmi forårsaget af bluetongue-virus, serotype 1 og 8, hos dyr fra de er halvanden måned gamle.
English: ZULVAC 1+8 Ovis is a vaccine.
Danish: ZULVAC 1+8 Ovis er en vaccine.
English: ZULVAC 1+8 Ovis contains bluetongue viruses that have been inactivated so that they cannot cause the disease.
Danish: ZULVAC 1+8 Ovis indeholder bluetongue-vira, som er blevet inaktiveret, så de ikke kan fremkalde sygdommen.
English: ZULVAC 1+8 Ovis is a vaccine that contains inactivated (killed) bluetongue serotypes 1 and 8 viruses as the active substance.
Danish: ZULVAC 1+8 Ovis er en vaccine, der indeholder inaktiveret (dræbt) bluetongue-virus, serotype 1 og 8, som aktivt stof.
English: The CVMP concluded that the benefits of ZULVAC 1+8 Ovis outweigh the risks for the prevention of viraemia caused by bluetongue virus, serotypes 1 and 8 in sheep from 1.5 months of age.
Danish: CVMP konkluderede, at fordelene ved ZULVAC 1+8 Ovis opvejer risiciene ved forebyggelse af viræmi forårsaget af bluetongue-virus, serotype 1 og 8, hos får i alderen halvanden måned og derover.
English: ZULVAC 1+8 Ovis is used in sheep to protect them against bluetongue disease, an infection caused by the bluetongue virus which is transmitted by midges.
Danish: ZULVAC 1+8 Ovis anvendes til får som beskyttelse mod sygdommen bluetongue, en infektion forårsaget af bluetongue-virus, der overføres gennem mitter.
English: When it is given to sheep and cattle, the immune system recognises the viruses as ‘foreign' and makes antibodies against them.
Danish: opfatter immunsystemet viraene som "fremmede" og producerer antistoffer mod dem.
English: Other information about ZULVAC 1+8 Ovis:
Danish: Andre oplysninger om ZULVAC 1+8 Ovis:
English: This means that it was not possible to obtain complete information about ZULVAC 1+8 Ovis at the time of the initial authorisation.
Danish: Det betyder, at det på tidspunktet for den oprindelige godkendelse ikke var muligt at indhente fyldestgørende oplysninger om ZULVAC 1+8 Ovis.
English: What is the risk associated with ZULVAC 1+8 Ovis?
Danish: Hvilken risiko er der forbundet med ZULVAC 1+8 Ovis?
English: Why has ZULVAC 1+8 Ovis been approved?
Danish: Hvorfor blev ZULVAC 1+8 Ovis godkendt?
English: What is ZULVAC 1+8 Ovis?
Danish: Hvad er ZULVAC 1+8 Ovis?
English: How has ZULVAC 1+8 Ovis been studied?
Danish: Hvordan blev ZULVAC 1+8 Ovis undersøgt?
English: What is ZULVAC 1+8 Ovis used for?
Danish: Hvad anvendes ZULVAC 1+8 Ovis til?
English: How does ZULVAC 1+8 Ovis work?
Danish: Hvordan virker ZULVAC 1+8 Ovis?
English: What benefit has ZULVAC 1+8 Ovis shown during the studies?
Danish: Hvilken fordel viser undersøgelserne, at der er ved ZULVAC 1+8 Ovis?
English: It is used for dogs and cats.
Danish: Det anvendes til hunde og katte.
English: This summary was last updated in December 2006.
Danish: Dette sammendrag blev sidst ajourført i 12-2006.
English: • transitory vomiting
Danish: • forbigående opkastning
English: These symptoms return to normal in the week after the last injection.
Danish: Disse symptomer svinder i ugen efter den sidste injektion.
English: Two further 5-day treatments must be carried out at 14 days, and 60 days after the first 5-day course.
Danish: Der gives yderligere to kure af 5 dages varighed henholdsvis 14 og 60 dage efter den første 5-dages kur.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Virbagen Omega to Virbac SA on 6 November 2001.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Virbagen Omega til Virbac SA den 6. november 2001.
English: • hyperthermia (increased temperature, 3-6 hours after injection)
Danish: • temperaturforhøjelse 3-6 timer efter injektionen
English: The mortality rate for dogs treated with Virbagen Omega was 4.4-6.4 times lower than that of the untreated animals.
Danish: Dødeligheden hos hunde behandlet med Virbagen Omega var 4,4-6,4 gange lavere end hos ubehandlede hunde.
English: There may be a slight decrease in white blood cells, platelets and red blood cells, and a rise in the concentration of alanine aminotransferase (a liver enzyme).
Danish: Der kan komme et let fald i hvide blodlegemer, blodplader og røde blodlegemer og en stigning i koncentrationen af alanin aminotransferase (et leverenzym).
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) VIRBAGEN OMEGA EPAR summary for the public
Danish: EUROPÆISK OFFENTLIG VURDERINGSRAPPORT (EPAR) VIRBAGEN OMEGA EPAR - sammendrag for offentligheden
English: The injection of Virbagen Omega may cause the following temporary symptoms in dogs and cats:
Danish: Injektion af Virbagen Omega kan være årsag til følgende forbigående symptomer hos hunde og katte:
English: Interferons are a family of naturally occurring proteins that are produced in response to viral infections.
Danish: Interferoner er en gruppe proteiner, der produceres naturligt som reaktion på virusinfektioner.
English: Virbagen Omega works by stimulating the immune system to attack the virus.
Danish: Virbagen Omega virker ved at stimulere immunsystemet til at angribe viruset.
English: Other information about Virbagen Omega:
Danish: Andre oplysninger om Virbagen Omega:
English: • fatigue during the treatment, in cats only
Danish: • træthed i behandlingsperioden (kun hos katte)
English: In cats infected by FIV, the mortality rate was low (5%) and was not changed by the treatment.
Danish: Hos katte, der var inficeret med FIV, var dødeligheden lav (5 %) og ændredes ikke ved behandlingen.
English: Virbagen Omega 2.5 MU/kg was given intravenously for 3 days.
Danish: Der blev givet Virbagen Omega 2,5 mio IE/kg intravenøst i 3 dage.
English: • soft faeces to mild diarrhoea, in cats only
Danish: • blød afføring til let diarré (kun hos katte)
English: In the population of cats (whether they were FeLV positive, FIV positive or co-infected by both viruses, there was a reduction of clinical signs over time, improving the quality of life of cats.
Danish: Hos alle kattene (hvad enten de var FeLV-positive, FIV-positive eller var inficeret med begge virus) indtrådte der en gradvis bedring i de kliniske symptomer, så at kattenes livskvalitet blev forbedret.
English: Cats: The suspension should be injected subcutaneously (under the skin) once daily for 5 consecutive days.
Danish: Katte: Suspensionen gives ved subkutan injektion (indsprøjtning under huden) én gang dagligt i 5 på hinanden følgende dage.
English: The dose is 1 MU/kg bodyweight.
Danish: Dosis er 1 mio IE/kg kropsvægt.
English: Virbagen Omega is a lyophilisate (freeze dried pellet) and solvent that is made into a suspension for injection.
Danish: Virbagen Omega er et lyofilisat (en frysetørret pellet) med opløsningsvæske, der benyttes til at fremstille en suspension til indsprøjtning.
English: The dose is 2.5 MU/kg bodyweight.
Danish: Dosis er 2,5 mio. IE/kg kropsvægt.
English: Dogs: The suspension should be injected intravenously (into a vein) once daily for 3 consecutive days.
Danish: Hunde: Suspensionen gives ved intravenøs injektion (indsprøjtning i en vene) én gang dagligt i 3 på hinanden følgende dage.
English: The omega interferon is made by a cell that has received a gene (DNA), which makes it able to produce omega interferon.
Danish: Omega interferon produceres af en celle, der har fået indsat et gen (dna), som gør den i stand til at producere stoffet.
English: They recommended that Virbagen Omega should be given a marketing authorisation.
Danish: Udvalget anbefalede udstedelse af markedsføringstilladelse for Virbagen Omega.
English: Virbagen Omega contains the active substance recombinant omega interferon.
Danish: Virbagen Omega indeholder det aktive stof rekombinant omega interferon.
English: Why has Virbagen Omega been approved?
Danish: Hvorfor blev Virbagen Omega godkendt?
English: Virbagen Omega is used to reduce mortality and clinical signs of parvovirosis (a highly contagious viral infection of dogs) in dogs from one month of age.
Danish: Virbagen Omega anvendes til at forebygge dødelighed og mindske de kliniske tegn på parvovirose (en meget smitsom virussygdom) hos hunde, der er over én måned gamle.
English: What is the risk associated with Virbagen Omega?
Danish: Hvilken risiko er der forbundet med Virbagen Omega?
English: In the treatment of cats with FeLV, there was a reduction of clinical signs over 4 months and a reduction in the mortality rate.
Danish: Hos katte med FeLV fik behandlingen de kliniske symptomer til at aftage i løbet af fire måneder, og dødeligheden var mindre.
English: The replacement omega interferon acts in the same way as naturally produced omega interferon.
Danish: Det kunstigt fremstillede omega interferon virker på samme måde som naturligt produceret omega interferon.
English: The main measure of effectiveness was the mortality rate compared with dogs that had not been treated.
Danish: virkning blev hovedsagelig bedømt ved sammenligning af dødeligheden hos de behandlede og de ubehandlede hunde.
English: The active substance of Virbagen Omega, omega interferon, is produced by a method known as ‘recombinant technology'.
Danish: Det aktive stof i Virbagen Omega, omega interferon, fremstilles ved "rekombinant teknologi".
English: The Committee for Medicinal Products for Veterinary Use (CVMP) agreed that the benefits of Virbagen Omega are greater than any risks to reduce mortality and clinical signs of parvovirosis in dogs from one month of age, and to treat cats infected with FeLV (feline leukaemia virus) and/or FIV in non-terminal cats from the age of 9 weeks.
Danish: Udvalget for Veterinærlægemidler (CVMP) fandt, at fordelene ved Virbagen Omega er større end risiciene til mindskelse af dødelighed og kliniske tegn ved parvovirose hos hunde over én måned gamle og til behandling af infektion med FeLV (felin leukæmivirus) og/eller FIV hos katte, som er over ni uger gamle, og hvis tilstand ikke er kritisk.
English: What is Virbagen Omega?
Danish: Hvad er Virbagen Omega?
English: How has the effectiveness of Virbagen Omega been studied?
Danish: Hvordan blev virkningen af Virbagen Omega undersøgt?
English: The main measure of effectiveness was the mortality rate compared with cats that had not been treated and clinical signs after treatment.
Danish: Behandlingens virkning blev hovedsagelig bedømt ved sammenligning af dødeligheden og de kliniske tegn hos de behandlede og ubehandlede katte.